Data / Drug companies / Hikma Pharmaceuticals USA Inc.
Hikma Pharmaceuticals USA Inc.: 10 products in the FDA NDC directory, labeler code 24201
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Hikma Pharmaceuticals USA Inc. (labeler code 24201) lists 10 products in the FDA National Drug Code Directory, covering 9 finished drugs by generic name. By type: 10 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on October 1, 2025.
The request: Watch Hikma Pharmaceuticals USA Inc. (FDA labeler code 24201): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 24201
- Products in commercial distribution
- 10
- Packages
- 13
- Finished drugs by generic name
- 9
- Prescription products
- 10
- Over the counter products
- 0
- Controlled substance products
- Schedule II 1
- Flagged as original packager
- 10 of 10 products that carry the flag
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- April 23, 2019
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 9 | 90% |
| New drug applications (NDA) | 1 | 10% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 10 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Acetaminophen | 2 | 214 |
| Icatibant | 1 | 8 |
| Medroxyprogesterone acetate | 1 | 23 |
| Pentobarbital sodium | 1 | 2 |
| Sodium tetradecyl sulfate | 1 | 2 |
| Dihydroergotamine mesylate | 1 | 13 |
| Levothyroxine sodium | 1 | 44 |
| Valrubicin intravesical solution | 1 | 1 |
| Calcitonin salmon | 1 | 13 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection, solution | 7 | 70% |
| Injection, suspension | 1 | 10% |
| Spray | 1 | 10% |
| Solution, concentrate | 1 | 10% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Bradykinin B2 Receptor Antagonist | 1 |
| Progestin | 1 |
| Ergotamine Derivative | 1 |
| l-Thyroxine | 1 |
| Calcitonin | 1 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Pentobarbital Sodium | 24201-010 | Injection, solution | Generic drugs (ANDA) | October 1, 2025 |
| Medroxyprogesterone Acetate Injectable Suspension | 24201-150 | Injection, suspension | Generic drugs (ANDA) | May 1, 2023 |
| Acetaminophen | 24201-110 | Injection, solution | Generic drugs (ANDA) | March 1, 2023 |
| Acetaminophen | 24201-100 | Injection, solution | Generic drugs (ANDA) | March 1, 2023 |
| Levothyroxine Sodium | 24201-002 | Injection, solution | New drug applications (NDA) | November 15, 2022 |
| Calcitonin Salmon | 24201-400 | Injection, solution | Generic drugs (ANDA) | May 14, 2021 |
| Dihydroergotamine Mesylate | 24201-463 | Spray | Generic drugs (ANDA) | April 14, 2020 |
| Icatibant | 24201-207 | Injection, solution | Generic drugs (ANDA) | March 9, 2020 |
| Sodium Tetradecyl Sulfate | 24201-201 | Injection, solution | Generic drugs (ANDA) | December 9, 2019 |
| Valrubicin Intravesical Solution | 24201-101 | Solution, concentrate | Generic drugs (ANDA) | April 23, 2019 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.